摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[(S)-2-N-BOC-amino-1-propyloxy]-2-chloro-3-methyl pyridine | 352704-62-2

中文名称
——
中文别名
——
英文名称
5-[(S)-2-N-BOC-amino-1-propyloxy]-2-chloro-3-methyl pyridine
英文别名
tert-butyl N-[(2S)-1-(6-chloro-5-methylpyridin-3-yl)oxypropan-2-yl]carbamate
5-[(S)-2-N-BOC-amino-1-propyloxy]-2-chloro-3-methyl pyridine化学式
CAS
352704-62-2
化学式
C14H21ClN2O3
mdl
——
分子量
300.785
InChiKey
YZGAGSUPZHLRAW-JTQLQIEISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    60.4
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-[(S)-2-N-BOC-amino-1-propyloxy]-2-chloro-3-methyl pyridine氢气 作用下, 生成 (2S)-1-(6-chloro-5-methylpyridin-3-yl)oxypropan-2-amine
    参考文献:
    名称:
    Synthesis and biological evaluation of pyridine-modified analogues of 3-(2-Aminoethoxy)pyridine as novel nicotinic receptor ligands
    摘要:
    Analogues of the potent nicotinic receptor agonist 3-(2-aminoethoxy)pyridine substituted at the 5' and 6'-positions of the pyridine ring were synthesized and tested in vitro for nicotinic receptor binding activity (displacement of [H-3](-)cytisine from whole rat brain synaptic membranes). The substituted analogues exhibited K-i values ranging from 0.076 to 319 nM compared to a K-i value of 26 nM for compound 1. Among the compounds tested, 5'-vinyl-6'-chloro substituted I was the most potent. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00740-0
  • 作为产物:
    参考文献:
    名称:
    Synthesis and biological evaluation of pyridine-modified analogues of 3-(2-Aminoethoxy)pyridine as novel nicotinic receptor ligands
    摘要:
    Analogues of the potent nicotinic receptor agonist 3-(2-aminoethoxy)pyridine substituted at the 5' and 6'-positions of the pyridine ring were synthesized and tested in vitro for nicotinic receptor binding activity (displacement of [H-3](-)cytisine from whole rat brain synaptic membranes). The substituted analogues exhibited K-i values ranging from 0.076 to 319 nM compared to a K-i value of 26 nM for compound 1. Among the compounds tested, 5'-vinyl-6'-chloro substituted I was the most potent. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00740-0
点击查看最新优质反应信息

文献信息

  • Substituted pyridine compounds useful for controlling chemical synaptic transmission
    申请人:——
    公开号:US20010034357A1
    公开(公告)日:2001-10-25
    The present invention is directed to a series of substituted pyridine compounds, a method for selectively controlling neurotransmitter release in mammals using these compounds, and pharmaceutical compositions containing these compounds. Preferred compounds are 3′-(5′- and/or 6′-substituted) pyridyl ethers.
    本发明涉及一系列取代吡啶化合物,一种利用这些化合物在哺乳动物中选择性控制神经递质释放的方法,以及含有这些化合物的药物组合物。首选的化合物是3′-(5′-和/或6′-取代)吡啶醚。
  • SUBSTITUTED PYRIDINE COMPOUNDS USEFUL FOR CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION
    申请人:ABBOTT LABORATORIES
    公开号:EP1257535B1
    公开(公告)日:2007-05-23
  • US6656958B2
    申请人:——
    公开号:US6656958B2
    公开(公告)日:2003-12-02
  • Synthesis and biological evaluation of pyridine-modified analogues of 3-(2-Aminoethoxy)pyridine as novel nicotinic receptor ligands
    作者:Nan-Horng Lin、Liming Dong、William H Bunnelle、David J Anderson、Michael D Meyer
    DOI:10.1016/s0960-894x(02)00740-0
    日期:2002.11
    Analogues of the potent nicotinic receptor agonist 3-(2-aminoethoxy)pyridine substituted at the 5' and 6'-positions of the pyridine ring were synthesized and tested in vitro for nicotinic receptor binding activity (displacement of [H-3](-)cytisine from whole rat brain synaptic membranes). The substituted analogues exhibited K-i values ranging from 0.076 to 319 nM compared to a K-i value of 26 nM for compound 1. Among the compounds tested, 5'-vinyl-6'-chloro substituted I was the most potent. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多